Imviva Biotech Announces Seven Presentations Highlighting its ANSWER(TM) Allogeneic CAR-T Platform at the 67th American Society of Hematology Annual Meeting
Imviva Biotech Announces Seven Presentations Highlighting its ANSWER(TM) Allogeneic CAR-T Platform at the 67th American Society of Hematology Annual Meeting GlobeNewswire November 24, 2025 Two oral, and five poster presentations will showcase the company's progress in developing allogenic cell therapy candidates for multiple hematological malignancies CTD402 data for the treatment of T-ALL/LBL selected as a […]